Risk of death and hospital admission for major medical events after initiation of psychotropic medications in older adults admitted to nursing homes
- 28 March 2011
- journal article
- Published by CMA Impact Inc. in CMAJ : Canadian Medical Association Journal
- Vol. 183 (7), E411-E419
- https://doi.org/10.1503/cmaj.101406
Abstract
Background Despite safety-related concerns, psychotropic medications are frequently prescribed to manage behavioural symptoms in older adults, particularly those with dementia. We assessed the comparative safety of different classes of psychotropic medications used in nursing home residents. Methods We identified a cohort of patients who were aged 65 years or older and had initiated treatment with psychotropics after admission to a nursing home in British Columbia between 1996 and 2006. We used proportional hazards models to compare rates of death and rates of hospital admissions for medical events within 180 days after treatment initiation. We used propensity-score adjustments to control for confounders. Results Of 10 900 patients admitted to nursing homes, atypical antipsychotics were initiated by 1942, conventional antipsychotics by 1902, antidepressants by 2169 and benzodiazepines by 4887. Compared with users of atypical antipsychotics, users of conventional antipsychotics and antidepressants had an increased risk of death (rate ratio [RR] 1.47, 95% confidence interval [CI] 1.14–1.91 for conventional antipsychotics and RR 1.20, 95% CI 0.96–1.50 for antidepressants), and an increased risk of femur fracture (RR 1.61, 95% CI 1.03–2.51 for conventional antipsychotics and RR 1.29, 95% CI 0.86–1.94 for antidepressants). Users of benzodiazepines had a higher risk of death (RR 1.28, 95% CI 1.04–1.58) compared with users of atypical antipsychotics. The RR for heart failure was 1.54 (95% CI 0.89–2.67), and for pneumonia it was 0.85 (95% CI 0.56–1.31). Interpretation Among older patients admitted to nursing homes, the risks of death and femur fracture associated with conventional antipsychotics, antidepressants and benzodiazepines are comparable to or greater than the risks associated with atypical antipsychotics. Clinicians should weigh these risks against the potential benefits when making prescribing decisions.Keywords
This publication has 26 references indexed in Scilit:
- Covariate Selection in High-Dimensional Propensity Score Analyses of Treatment Effects in Small SamplesAmerican Journal of Epidemiology, 2011
- Confounding Control in Healthcare Database ResearchMedical Care, 2010
- A basic study design for expedited safety signal evaluation based on electronic healthcare dataPharmacoepidemiology and Drug Safety, 2010
- All-Cause Mortality Associated With Atypical and Conventional Antipsychotics Among Nursing Home Residents With DementiaPublished by Physicians Postgraduate Press, Inc ,2009
- High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims DataEpidemiology, 2009
- Antipsychotic Therapy and Short-term Serious Events in Older Adults With DementiaJAMA Internal Medicine, 2008
- Antipsychotic Drug Use and Risk of Pneumonia in Elderly PeopleJournal of the American Geriatrics Society, 2008
- ACNP White Paper: Update on Use of Antipsychotic Drugs in Elderly Persons with DementiaNeuropsychopharmacology, 2007
- Antipsychotic Drug Use and Mortality in Older Adults with DementiaAnnals of Internal Medicine, 2007
- Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patientsCMAJ : Canadian Medical Association Journal, 2007